BusinessPhoto: Hindu BusinessAurobindo Pharma Q2 Net Profit Rises 32.5% to ₹1,124 Crore
Aurobindo Pharma reported a 32.5% year-on-year increase in consolidated net profit to ₹1,124 crore for the quarter ended September, driven by a 24% rise in revenue to ₹10,263 crore, the highest quarterly revenue to date. The company declared an interim dividend of ₹7 per share. Sequential growth was modest compared to the previous quarter's ₹1,032 crore profit and ₹9,150 crore revenue.
Hindu Business··Hyderabad


